About
Cannabis-based Treatment Solutions
CannaMore is a preclinical- and clinical-stage research platform company committed to the development of novel and improved cannabis-based treatment options that will potentially benefit millions of patients worldwide.
The company is focusing on the development of a CBD-based solution for the treatment of bronchiolitis obliterans, peripheral neuropathy, and inflammatory bowel diseases.
CannaMore is a portfolio company of BioSeedXL.
Identity
| Name | Cannamore Biotechs |
|---|---|
| Slug | cannamore-biotechs |
| Type / kind | startup |
| Crunchbase ID | cannamore-biotechs |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4OqU0ZULDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Bnei Brak |
| HQ address | Barukh Hirsch St 18, Bnei Brak, Israel |
Web & social
| Website | https://cannamorebio.com |
|---|---|
| https://www.linkedin.com/company/42950635 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisDrugs Discovery & Development
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticalsHealthcareLaboratories
Business models
B2B
Tags
pharmaceuticalsbiopharmaceuticaltreatmentsinflammatory-diseasesmedical-cannabispharma-companies
Funding
| Total raised | — |
|---|---|
| Current stage | Pre-Funding |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}